Introduction. Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes. Several studies conducted in different hospitals revealed a high incidence of inappropriate prescription of beta-blockers among hospitalized patients. Therefore, it is important to identify inappropriate beta-blocker prescribing since they may increase the risk of hospitalizations. Despite this, there was no study conducted related to drug use evaluation of beta-blockers in Nedjo general hospital (NGH). Thus, this study was aimed at assessing the use evaluation of beta-blockers in medical wards of NGH. Methods. A retrospective cross-sectional study was conducted at medical wards of NGH from January 1, 2016, to December 31, 2017. Results. Out of the total of 149 medical record of patients that contains beta-blockers, 84 (56.37%) were males and about one-third (31.54%) of the patients ages were between 41 and 50 years. Propranolol was the most commonly prescribed beta-blocker (62.76%), and 94.56% of beta-blockers were prescribed with correct indication. There were about 51%, 46.31%, 64.43%, and 46.98% of beta-blockers prescribed with the correct dose, duration, frequency, and route of administration, respectively. Regarding the routes of administration, 70 (46.98%) of them were prescribed with the correct route. Most drugs interacting were propranolol with cimetidine 26 (68.42%), and the most frequent condition for which beta-blockers were prescribed was hypertension (32.89%). Conclusion. Overall, there was an inappropriate use of beta-blockers in terms of dosage and durations. So, prescribers of NGH should strictly adhere to the national treatment guideline when prescribing medications. Additionally, drug information centers have proved useful and effective in promoting rational drug use. Hence, it should be recommended for general use.

中文翻译：

---

埃塞俄比亚西部 Nedjo 总医院内科病房中 β 受体阻滞剂的药物使用评价。

简介。β受体阻滞剂使用评估是一种绩效方法，侧重于评估β受体阻滞剂使用过程以实现最佳患者结果。在不同医院进行的几项研究表明，住院患者中不适当的β受体阻滞剂处方的发生率很高。因此，识别不适当的β受体阻滞剂处方非常重要，因为它们可能会增加住院风险。尽管如此，Nedjo 综合医院 (NGH) 并未开展与β受体阻滞剂药物使用评估相关的研究。因此，本研究旨在评估 β 受体阻滞剂在 NGH 内科病房中的使用情况。方法。一项回顾性横断面研究于 2016 年 1 月 1 日至 2017 年 12 月 31 日在 NGH 内科病房进行。结果。在 149 份含有 β 受体阻滞剂的患者病历中，84 名（56.37%）为男性，约三分之一（31.54%）的患者年龄在 41 至 50 岁之间。普萘洛尔是最常用的 β 受体阻滞剂（62.76%），94.56% 的 β 受体阻滞剂处方正确。分别有 51%、46.31%、64.43% 和 46.98% 的 β 受体阻滞剂处方剂量、持续时间、频率和给药途径正确。关于给药途径，其中70例（46.98%）的给药途径正确。大多数相互作用的药物是普萘洛尔和西咪替丁 26 (68.42%)，最常见的 β 受体阻滞剂是高血压 (32.89%)。结论. 总体而言，就剂量和持续时间而言，β-受体阻滞剂的使用不当。因此，NGH的处方者在开药时应严格遵守国民治疗指南。此外，事实证明，药物信息中心在促进合理用药方面是有用和有效的。因此，应建议将其用于一般用途。